AU2002344717A1 - Method of inducing apoptosis in cancer cells - Google Patents

Method of inducing apoptosis in cancer cells

Info

Publication number
AU2002344717A1
AU2002344717A1 AU2002344717A AU2002344717A AU2002344717A1 AU 2002344717 A1 AU2002344717 A1 AU 2002344717A1 AU 2002344717 A AU2002344717 A AU 2002344717A AU 2002344717 A AU2002344717 A AU 2002344717A AU 2002344717 A1 AU2002344717 A1 AU 2002344717A1
Authority
AU
Australia
Prior art keywords
cancer cells
inducing apoptosis
apoptosis
inducing
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002344717A
Inventor
Robert Charles Baxter
Alison Joy Butt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sydney
Original Assignee
University of Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sydney filed Critical University of Sydney
Publication of AU2002344717A1 publication Critical patent/AU2002344717A1/en
Abandoned legal-status Critical Current

Links

AU2002344717A 2001-07-13 2002-07-15 Method of inducing apoptosis in cancer cells Abandoned AU2002344717A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR6331 2001-07-13

Publications (1)

Publication Number Publication Date
AU2002344717A1 true AU2002344717A1 (en) 2003-01-29

Family

ID=

Similar Documents

Publication Publication Date Title
AUPS054702A0 (en) Cancer therapy
AU2003215460A1 (en) Cancer associated protein kinases and their uses
AU2002338446A1 (en) Methods of producing or identifying intrabodies in eukaryotic cells
AU2003235470A1 (en) Predictive markers in cancer therapy
AU2003262833A1 (en) Fluorescent glycosides and methods for their use
AU2002252160A1 (en) Connexin enhances chemotherapy-induced apoptosis in human cancer cells inhibiting tumor cell proliferation
AU2003256847A1 (en) Method of treating cancer
AU2003212634A1 (en) Compounds useful in the treatment of cancer
AU2002341717A1 (en) Cell therapy system
AU2002308522A1 (en) Methods for inhibiting tumor cell proliferation
AU2001294617A1 (en) Method of inducing apoptosis in lymphoid cells
AU2002307154A1 (en) Prostate cancer expression profiles
AU2002244055A1 (en) Fra-1 expression in brain cancer
AU2003224085A1 (en) Waveguide in porous substrates
AU2003223538A1 (en) Methods for the treatment of cancer
AU2002366310A1 (en) Method of inducing apoptosis and compositions therefor
AU2002303230A1 (en) Combined hydrotreating and process
AU2002362613A1 (en) Galectins-1-and-4 in tumor development
AU2001256555A1 (en) New inhibotor of apoptosis of nerve cells
AU2003227861A1 (en) Protein involved in cancer
AU2002215111A1 (en) Ruthenium-aryl-compounds in cancer therapy
AU2003283339A1 (en) Cancer therapy determination
AU2003231803A1 (en) Treatment of cancer with mefloquire
AU2002344717A1 (en) Method of inducing apoptosis in cancer cells
AU2003302625A1 (en) Silicon compounds useful in cancer therapy